{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T21:24:27Z","timestamp":1778102667766,"version":"3.51.4"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"36","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1097\/md.0000000000012227","type":"journal-article","created":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T09:22:20Z","timestamp":1536225740000},"page":"e12227","source":"Crossref","is-referenced-by-count":15,"title":["The role of fluorescence in situ hybridization to predict patient response to intravesical Bacillus Calmette\u2013Gu\u00e9rin therapy for bladder cancer"],"prefix":"10.1097","volume":"97","author":[{"given":"Yige","family":"Bao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Tu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiancong","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shi","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiwen","family":"Geng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liuliu","family":"Quan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-88-20210826","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0094-0143(05)70229-9","article-title":"The natural history of bladder cancer. Implications for therapy","volume":"27","author":"Lee","year":"2000","journal-title":"Urol Clin N Am"},{"key":"R2-88-20210826","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.eururo.2008.04.051","article-title":"EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder","volume":"59","author":"Babjuk","year":"2008","journal-title":"Eur Urol"},{"key":"R3-88-20210826","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.juro.2016.06.049","article-title":"Diagnosis and treatment of non-muscle invasive bladder cancer: AUA\/SUO guideline","volume":"196","author":"Chang","year":"2016","journal-title":"J Urol"},{"key":"R4-88-20210826","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1046\/j.1464-410X.1998.00720.x","article-title":"Bacille Calmette-Gu\u00e9rin in superficial transitional cell carcinoma","volume":"82","author":"Mungan","year":"1998","journal-title":"Br J Urol"},{"key":"R5-88-20210826","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/01.ju.0000132129.87598.3b","article-title":"Primary T1G3 bladder cancer: organ preserving approach or immediate cystectomy?","volume":"172","author":"Thalmann","year":"2004","journal-title":"J Urol"},{"key":"R6-88-20210826","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1078-1439(02)00239-9","article-title":"Is bladder biopsy necessary at three or six months post BCG therapy?","volume":"21","author":"Highshaw","year":"2003","journal-title":"Urol Oncol"},{"key":"R7-88-20210826","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.juro.2009.08.150","article-title":"Cystoscopy revisited as the gold standard for detecting bladder cancer recurrence: diagnostic review bias in the randomized, prospective CEFUB trial","volume":"183","author":"van der Aa","year":"2010","journal-title":"J Urol"},{"key":"R8-88-20210826","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0165-4608(93)90015-E","article-title":"A new approach in the diagnosis and follow-up of bladder cancer. FISH analysis of urine, bladder washings, and tumors","volume":"71","author":"Meloni","year":"1993","journal-title":"Cancer Gene Cytogenet"},{"key":"R9-88-20210826","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/j.1464-410X.2003.04528.x","article-title":"Comparison of multitarget fluorescence in situ hybridization in urine with other noninvasive tests for detecting bladder cancer","volume":"92","author":"Grossman","year":"2003","journal-title":"Br J Urol Int"},{"key":"R10-88-20210826","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1016\/S0022-5347(05)64270-X","article-title":"Clinical evaluation of a multi-target fluorescent in situ hybridization assay for detection of bladder cancer","volume":"168","author":"Sarosdy","year":"2002","journal-title":"J Urol"},{"key":"R11-88-20210826","first-page":"e123","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"18","author":"Moher","year":"2009","journal-title":"Rev Esp Nutr Hum Diet"},{"key":"R12-88-20210826","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/S0022-5347(05)65072-0","article-title":"A comparison of BTA stat, hemoglobin dipstick, telomerase and Vysis UroVysion assays for the detection of urothelial carcinoma in urine","volume":"167","author":"Halling","year":"2002","journal-title":"J Urol"},{"key":"R13-88-20210826","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies","volume":"155","author":"Whiting","year":"2011","journal-title":"Ann Intern Med"},{"key":"R14-88-20210826","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"Br Med J"},{"key":"R15-88-20210826","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/01.ju.0000149825.83180.a4","article-title":"Monitoring intravesical therapy for superficial bladder cancer using fluorescence in situ hybridization","volume":"173","author":"Kipp","year":"2005","journal-title":"J Urol"},{"key":"R16-88-20210826","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.eururo.2007.03.001","article-title":"Clinical utility of fluorescent in situ hybridization for the surveillance of bladder cancer patients treated with Bacillus Calmette-Gu\u00e9rin therapy","volume":"52","author":"Mengual","year":"2007","journal-title":"Eur Urol"},{"key":"R17-88-20210826","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1464-410X.2009.08375.x","article-title":"A multicolour fluorescence in situ hybridization test predicts recurrence in patients with high-risk superficial bladder tumours undergoing intravesical therapy","volume":"104","author":"Whitson","year":"2009","journal-title":"BJU Int"},{"key":"R18-88-20210826","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1002\/ijc.24258","article-title":"The prognostic value of cytology and fluorescence in situ hybridization in the follow-up of nonmuscle-invasive bladder cancer after intravesical Bacillus Calmette-Gu\u00e9rin therapy","volume":"124","author":"Savic","year":"2009","journal-title":"Int J Cancer"},{"key":"R19-88-20210826","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.juro.2011.10.144","article-title":"Use of fluorescence in situ hybridization to predict response to bacillus Calmette-Gu\u00e9rin therapy for bladder cancer: results of a prospective trial","volume":"187","author":"Kamat","year":"2012","journal-title":"J Urol"},{"key":"R20-88-20210826","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/s12032-017-1033-z","article-title":"Fluorescence in situ hybridization as prognostic predictor of tumor recurrence during treatment with Bacillus Calmette\u2013Gu\u00e9rin therapy for intermediate- and high-risk non-muscle-invasive bladder cancer","volume":"34","author":"Liem","year":"2017","journal-title":"Med Oncol"},{"key":"R21-88-20210826","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/cyt.12064","article-title":"Assessing treatment response after induction Bacillus Calmette-Guerin for carcinoma in situ of the urinary bladder: can post-induction random bladder biopsies be avoided?","volume":"25","author":"Smith","year":"2014","journal-title":"Cytopathology"},{"key":"R22-88-20210826","doi-asserted-by":"crossref","first-page":"338","DOI":"10.3109\/21681805.2015.1009484","article-title":"Are cystoscopy and urinary cytology sufficient to identify candidates for subsequent biopsy after bacillus Calmette-Guerin treatment in patients with bladder carcinoma in situ?","volume":"49","author":"Haase","year":"2015","journal-title":"Scand J Urol"},{"key":"R23-88-20210826","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1016\/S0022-5347(05)67104-2","article-title":"A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma","volume":"164","author":"Halling","year":"2000","journal-title":"J Urol"},{"key":"R24-88-20210826","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.1464-410X.2012.11754.x","article-title":"Bacillus Calmette\u2013Gu\u00e9rin immunotherapy for genitourinary cancer","volume":"112","author":"Ghi","year":"2013","journal-title":"BJU Int"},{"key":"R25-88-20210826","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0022-5347(01)64079-5","article-title":"Does topical instillation therapy influence chromosomal aberrations in superficial bladder cancer?","volume":"159","author":"Pycha","year":"1998","journal-title":"J Urol"},{"key":"R26-88-20210826","first-page":"181","article-title":"The value of a second transurethral resection in evaluating patients with bladder tumours","volume":"29","author":"Miladi","year":"2003","journal-title":"Int Braz J Urol"},{"key":"R27-88-20210826","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/S0022-5347(05)66532-9","article-title":"Second resection and prognosis of primary high risk superficial bladder cancer: is cystectomy often too early?","volume":"165","author":"Brauers","year":"2001","journal-title":"J Urol"},{"key":"R28-88-20210826","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S0022-5347(05)64043-8","article-title":"Intravesical bacillus calmette-guerin versus mitomycin C for superficial bladder cancer: a formal meta-analysis of comparative studies on recurrence and toxicity","volume":"169","author":"B\u00f6hle","year":"2003","journal-title":"J Urol"},{"key":"R29-88-20210826","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/path.1175","article-title":"Patterns of chromosomal aberrations in urinary bladder tumours and adjacent urothelium","volume":"198","author":"Steidl","year":"2002","journal-title":"J Pathol"},{"key":"R30-88-20210826","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1097\/01.ju.0000066842.45464.cc","article-title":"Multitarget fluorescence in situ hybridization assay detects transitional cell carcinoma in the majority of patients with bladder cancer and atypical or negative urine cytology","volume":"169","author":"Skacel","year":"2003","journal-title":"J Urol"},{"key":"R31-88-20210826","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1016\/S0022-5347(01)66039-7","article-title":"Clinical evaluation of cell deoxyribonucleic acid content measured by flow cytometry in bladder cancer","volume":"155","author":"Bittard","year":"1996","journal-title":"J Urol"},{"key":"R32-88-20210826","first-page":"2860","article-title":"Marked genetic differences between stage pTa and stage pT1 papillary bladder cancer detected by comparative genomic hybridization","volume":"57","author":"Richter","year":"1997","journal-title":"Cancer Res"},{"key":"R33-88-20210826","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3322\/canjclin.48.5.269","article-title":"Bladder cancer: state - of - the - art care","volume":"48","author":"Droller","year":"1998","journal-title":"CA Cancer J Clin"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00005792-201809070-00088","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,26]],"date-time":"2021-08-26T14:28:23Z","timestamp":1629988103000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201809070-00088"}},"subtitle":["A diagnostic meta-analysis and systematic review"],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":33,"journal-issue":{"issue":"36","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000012227","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]}}}